TREROTOLA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.421
EU - Europa 1.355
AS - Asia 858
SA - Sud America 52
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.694
Nazione #
US - Stati Uniti d'America 1.409
SG - Singapore 413
IT - Italia 398
CN - Cina 228
IE - Irlanda 205
SE - Svezia 177
TR - Turchia 141
UA - Ucraina 115
GB - Regno Unito 105
FR - Francia 91
DE - Germania 87
AT - Austria 52
FI - Finlandia 46
BR - Brasile 45
IN - India 25
RU - Federazione Russa 18
CZ - Repubblica Ceca 16
HK - Hong Kong 16
NL - Olanda 12
BE - Belgio 11
VN - Vietnam 11
CA - Canada 9
CH - Svizzera 8
JP - Giappone 8
ES - Italia 4
IQ - Iraq 4
AR - Argentina 2
EU - Europa 2
ID - Indonesia 2
LT - Lituania 2
MA - Marocco 2
PK - Pakistan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CO - Colombia 1
DO - Repubblica Dominicana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KR - Corea 1
KZ - Kazakistan 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
TN - Tunisia 1
VE - Venezuela 1
Totale 3.694
Città #
Chandler 279
Singapore 273
Dublin 205
Jacksonville 179
Princeton 84
Ann Arbor 80
Pescara 78
Izmir 72
Southend 72
Chieti 68
Dearborn 65
Santa Clara 62
Wilmington 55
Nanjing 50
Beijing 47
Vienna 45
Ashburn 44
Boardman 35
Altamura 34
Milan 32
The Dalles 31
Woodbridge 28
Cambridge 26
Rome 20
Nanchang 19
Houston 18
Brno 15
Montesilvano 15
Nuremberg 15
New York 14
Shenyang 14
Helsinki 13
Hong Kong 13
Ancona 11
Brussels 11
Dong Ket 11
Lappeenranta 11
Seattle 11
Chicago 9
Hebei 9
Jiaxing 9
Los Angeles 9
Tianjin 9
London 8
Munich 8
Zurich 8
Changsha 7
Frankfurt am Main 6
Grevenbroich 6
Guglionesi 6
Kunming 6
Oakland 6
Toronto 6
Washington 6
Coimbatore 5
Collecorvino 5
Hefei 5
Horley 5
Jinan 5
Lanciano 5
Amsterdam 4
Ascoli Piceno 4
Bologna 4
Guangzhou 4
Norwalk 4
Romola 4
San Vito Chietino 4
Sulmona 4
Baghdad 3
Castignano 3
Fairfield 3
Grafing 3
Granada 3
Hangzhou 3
Istanbul 3
Ningbo 3
Padova 3
Paris 3
Bandung 2
Busseto 2
Carini 2
Chongqing 2
Fortaleza 2
Francavilla Al Mare 2
Lanzhou 2
Leicester 2
L’Aquila 2
Menlo Park 2
Miglianico 2
Montevideo 2
Portsmouth 2
Praia Grande 2
Reston 2
Ribeirão Preto 2
San Benedetto del Tronto 2
San Diego 2
Shijiazhuang 2
Somerville 2
Spoltore 2
Stockholm 2
Totale 2.409
Nome #
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer 183
Novel anti-Trop-2 monoclonal antibodies with unique binding specifıcities show therapeutic synergy against most human cancers 145
Trop-2 is a determinant of breast cancer survival. 136
A unique four-hub protein cluster associates to glioblastoma progression 131
Trop-2 activates a dormant Na/K-ATPase/PKCa/CD9/ezrin signaling axis to override the basal growth program of cancer cells 119
The Trop-2 signalling network in cancer growth 103
CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells 102
Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics 102
Human amniotic membrane sub-regions show different morpho-functional features useful in the field of regenerative medicine 101
Use of circulating serum trop-2 as new tumor biomarker 101
[Proteomics analysis of solid tumors] 98
Epigenetic inheritance and the missing heritability 96
Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors 95
IGF-IR Promotes Prostate Cancer Growth by Stabilizing α5β1 Integrin Protein Levels 93
Upregulation of Trop-2 quantitatively stimulates human cancer growth 92
Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells 91
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 91
Detection and analysis of spliced chimeric mRNAs in sequence databanks 90
Novel domain-targeted anti-Trop-2 monoclonal antibodies to elicit therapeutic synergy against multiple human cancers. 90
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion 89
Uso di Trop-2 circolante sierico come nuovo biomarcatore tumorale 88
Abandoning the Notion of Non-Small Cell Lung Cancer 88
Letter to the Editor: Efficacy and safety of anti-Trop antibodies, R. Cubas, M. Li, C. Chen and Q. Yao, Biochim Biophys Acta 1796 (2009) 309-1 87
Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer 85
Insulin-like growth factor 1 stimulation of androgen receptor activity requires β 1A integrins 81
A hidden human proteome signature characterizes the epithelial mesenchymal transition program 80
Long-range transcriptome sequencing reveals cancer cell growth regulatory chimeric mRNA 78
Distinct lung cancer subtypes associate to distinct drivers of tumor progression 77
The multiverse nature of epithelial to mesenchymal transition 76
Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis 74
β-Catenin Knockdown Affects Mitochondrial Biogenesis and Lipid Metabolism in Breast Cancer Cells. 74
Trop-2 promotes prostate cancer metastasis by modulating β1 integrin functions 72
Cancer-Homing CAR-T Cells and Endogenous Immune Population Dynamics 67
PSA regulates androgen receptor expression in prostate cancer cells 64
The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression 64
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer 64
Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts 59
null 56
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis 55
A deterministic code for transcription factor-DNA recognition through computation of binding interfaces 53
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 52
Rescue of secretion of rare‐disease‐associated misfolded mutant glycoproteins in UGGT1 knock‐out mammalian cells 41
null 35
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks 30
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability 29
Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion 28
The Protective Action of Metformin against Pro-Inflammatory Cytokine-Induced Human Islet Cell Damage and the Mechanisms Involved 27
Salivary proteome changes in response to acute psychological stress due to an oral exam simulation in university students: Effect of an olfactory stimulus 26
null 25
Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome 23
The SW480 cell line as a model of resident and migrating colon cancer stem cells 16
Unraveling the protein kinase C/NDRG1 signaling network in breast cancer 15
null 12
Targeting Trop-2 as a Cancer Driver 9
Large, recursive membrane platforms are associated to Trop-1, Trop-2 and protein kinase signaling for cell growth 8
Autophagy inhibitors in the treatment of colorectal cancer: a brief review 8
Inflammation and epithelial–mesenchymal transition in a CFTR‐depleted human bronchial epithelial cell line revealed by proteomics and human organ‐on‐a‐chip 5
A platform to obtain monoclonal antibodies directed against processed tumor-specific antigens 2
Piattaforma per ottenere anticorpi monoclonali diretti contro antigeni processati tumore-specifici 2
Insight into the Regulation of NDRG1 Expression 1
Totale 3.984
Categoria #
all - tutte 17.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 0 0 0 0 0 0 0 0 0 0 55 5
2020/2021273 34 7 60 29 12 38 26 6 22 12 5 22
2021/2022269 10 6 8 67 5 10 3 24 11 14 30 81
2022/2023772 56 128 44 75 60 144 42 86 88 5 29 15
2023/2024413 48 15 24 16 19 106 64 14 4 11 6 86
2024/20251.026 43 229 158 53 32 59 115 98 160 53 26 0
Totale 3.984